# Eicosapentaenoic Acid (EPA) for Treatment of Colorectal Cancer Liver Metastases

> **NCT01070355** · PHASE2 · COMPLETED · sponsor: **University of Leeds** · enrollment: 88 (actual)

## Conditions studied

- Colorectal Cancer

## Interventions

- **DRUG:** Eicosapentaenoic acid free fatty acid
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01070355
- **Lead sponsor:** University of Leeds
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2011-10
- **Final completion:** 2011-10
- **Target enrollment:** 88 (ACTUAL)
- **Last updated:** 2011-10-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01070355

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01070355, "Eicosapentaenoic Acid (EPA) for Treatment of Colorectal Cancer Liver Metastases". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01070355. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*